With Cronos Deal, Ginkgo Brings Synthetic Bio Approach to Cannabis | Enterpreneurship

In a partnership that gives new meaning to mixing pot and beer, Canadian cannabis company Cronos Group has teamed with synthetic biology firm Ginkgo Bioworks to try and develop better ways of producing the chemical compounds of cannabis in a lab.

Employees of Boston-based Ginkgo use robotic systems and software to design and test custom-made yeast and other microbes engineered to—in a process similar to brewing beer—secrete products such as rose-scented oil that goes into perfumes; sweeteners for beverages; and industrial enzymes used in laundry detergent. Ginkgo has been expanding its approach to additional sectors, including a $100 million joint venture… Read more »

Reprints | Share:

UNDERWRITERS AND PARTNERS